Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate-Lowering Therapy During Remission: A Mixed-Methods Study.
Iris Rose PeetersFrouwke VeenstraSophie A C WantenJohanna E VriezekolkCornelia H van den EndeAlfons A den BroederNoortje van HerwaardenLise M VerhoefMarcel FlendriePublished in: Arthritis care & research (2024)
These results can aid shared decision-making and provide input for what is important to discuss with patients with gout in remission when they consider ULT discontinuation. The emphasis should be on the risk of having gout flares and joint damage, not so much on facilitating how easily medication is received.